TENT5A and ovarian cancer: Further analysis of Kaplan-Meier plotter-Ovarian cancer datasets showed that ovarian cancer patients with higher FAM46A expression had a shorter survival time and an earlier relapse survival time (P < 0.05; Figure 1(d)).